Perioperative and long-term outcomes of laparoscopic liver resections for non-colorectal liver metastases
- PMID: 31586246
- DOI: 10.1007/s00464-019-07148-4
Perioperative and long-term outcomes of laparoscopic liver resections for non-colorectal liver metastases
Abstract
Background: Liver is a common metastatic site not only of colorectal but of non-colorectal neoplasms, as well. However, resection of non-colorectal liver metastases (NCRLMs) remains controversial. The aim of this retrospective study was to analyze the short- and long-term outcomes of patients undergoing laparoscopic liver resection (LLR) for NCRLMs.
Methods: From a prospectively maintained database between 2000 and 2018, patients undergoing LLR for colorectal liver metastases (CRLMs) and NCRLMs were selected. Clinicopathologic, operative, short- and long-term outcome data were collected, analyzed, and compared among patients with CRLMs and NCRLMs.
Results: The primary tumor was colorectal in 354 (82.1%), neuroendocrine in 21 (4.9%), and non-colorectal, non-neuroendocrine in the remaining 56 (13%) patients. Major postoperative morbidities were 12.7%, 19%, and 3.6%, respectively (p = 0.001), whereas the mortality was 0.6% for patients with CRLMs and zero for patients with NCRLMs. The rate of R1 surgical margin was comparable (p = 0.432) among groups. According to the survival analysis, 3- and 5-year recurrence-free survival (RFS) rates were 76.1% and 64.3% in the CRLM group, 57.1% and 42.3% in the neuroendocrine liver metastase (NELM) group, 33% and 20.8% in the non-colorectal, non-neuroendocrine liver metastase (NCRNNELM) group (p = 0.001), respectively. Three- and 5-year overall survival (OS) rates were 88.3% and 82.7% in the CRLM group, 85.7% and 70.6% in the NELM group, 71.4% and 52.9% in the NCRNNELM group (p = 0.001), respectively. In total, 113 out of 354 (31.9%) patients with CRLMs, 2 out of 21(9.5%) with NELMs, and 8 out of 56 (14.3%) patients with NCRNNELMs underwent repeat LLR for recurrent metastatic tumors.
Conclusion: LLR is safe and feasible in the context of a multimodal management where an aggressive surgical approach, necessitating even complex procedures for bilobar multifocal metastases and repeat hepatectomy for recurrences, is the mainstay and may be of benefit in the long-term survival, in selected patients with NCRNNELMs.
Keywords: Laparoscopic liver resection; Non-colorectal liver metastases; Overall; Postoperative outcomes; Recurrence-free survivals.
Similar articles
-
Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases.Surg Endosc. 2015 Sep;29(9):2736-47. doi: 10.1007/s00464-014-3999-3. Epub 2014 Nov 27. Surg Endosc. 2015. PMID: 25427420
-
Perioperative and recurrence-free survival outcomes after laparoscopic hepatectomy for colorectal cancer liver metastases using indocyanine green fluorescence imaging: an inverse probability treatment weighted analysis.Surg Endosc. 2025 Feb;39(2):1169-1181. doi: 10.1007/s00464-024-11478-3. Epub 2024 Dec 23. Surg Endosc. 2025. PMID: 39715956
-
Expanding indications for laparoscopic parenchyma-sparing resection of posterosuperior liver segments in patients with colorectal metastases: comparison with open hepatectomy for immediate and long-term outcomes.Surg Endosc. 2021 Jan;35(1):96-103. doi: 10.1007/s00464-019-07363-z. Epub 2020 Jan 13. Surg Endosc. 2021. PMID: 31932927
-
Resection margin status in laparoscopic liver resection for colorectal liver metastases: literature review and future perspectives.Minerva Surg. 2022 Oct;77(5):428-432. doi: 10.23736/S2724-5691.22.09568-5. Minerva Surg. 2022. PMID: 36331367 Review.
-
Laparoscopic hepatectomy for liver metastases from colorectal cancer: a meta-analysis.J Laparoendosc Adv Surg Tech A. 2014 Apr;24(4):213-22. doi: 10.1089/lap.2013.0399. Epub 2014 Feb 26. J Laparoendosc Adv Surg Tech A. 2014. PMID: 24571350 Review.
Cited by
-
Short- and long-term outcomes of surgery for colorectal and non-colorectal liver metastasis: a report from a single center in the Baltic country.World J Surg Oncol. 2020 Jul 14;18(1):164. doi: 10.1186/s12957-020-01944-2. World J Surg Oncol. 2020. PMID: 32664960 Free PMC article.
-
Retrospective Analysis of Postoperative Nonhepatic Outcomes Following Major Liver Resection.Cureus. 2024 May 14;16(5):e60311. doi: 10.7759/cureus.60311. eCollection 2024 May. Cureus. 2024. PMID: 38883004 Free PMC article.
-
Advances in liver transplantation for unresectable colon cancer liver metastasis.World J Gastrointest Surg. 2021 Dec 27;13(12):1615-1627. doi: 10.4240/wjgs.v13.i12.1615. World J Gastrointest Surg. 2021. PMID: 35070067 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical